{"title":"清洁发展机制已死","authors":"Joseph Anderson","doi":"10.14524/CR-15-4098","DOIUrl":null,"url":null,"abstract":"Few areas of clinical development have undergone as much change in the last 10 years as clinical data management (CDM). Its demise has been predicted and assumed for decades, aided and abetted by large consultancies and investors/analysts pressuring pharma for cost-cutting. These stakeholders saw (","PeriodicalId":90809,"journal":{"name":"Clinical researcher (Alexandria, Va.)","volume":"23 1","pages":"58-60"},"PeriodicalIF":0.0000,"publicationDate":"2015-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CDM IS DEAD\",\"authors\":\"Joseph Anderson\",\"doi\":\"10.14524/CR-15-4098\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Few areas of clinical development have undergone as much change in the last 10 years as clinical data management (CDM). Its demise has been predicted and assumed for decades, aided and abetted by large consultancies and investors/analysts pressuring pharma for cost-cutting. These stakeholders saw (\",\"PeriodicalId\":90809,\"journal\":{\"name\":\"Clinical researcher (Alexandria, Va.)\",\"volume\":\"23 1\",\"pages\":\"58-60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical researcher (Alexandria, Va.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14524/CR-15-4098\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical researcher (Alexandria, Va.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14524/CR-15-4098","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Few areas of clinical development have undergone as much change in the last 10 years as clinical data management (CDM). Its demise has been predicted and assumed for decades, aided and abetted by large consultancies and investors/analysts pressuring pharma for cost-cutting. These stakeholders saw (